Stock listing

Dusseldorf:LUP Luye Pharma Group Ltd. Aktie

German listing (Dusseldorf) of Luye Pharma Group Ltd. · home listing HKEX:2186

Follow Luye Pharma Group Ltd. into a list and get an email when it puts out news.

Home listing price · HKEX:2186

$1.48 HKD -0.06 (-4.2%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:2186

Past year -52.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.38 – $1.48 HKDNov 20, 2026
Volume
51.54M sharesNov 20, 2026
Market cap
$5.89B HKDAt the close on Nov 20, 2026 · price × 3.99B shares outstanding
52-week range
$1.38 – $3.22 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$51.95M HKDMedian day 23.76M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Luye Pharma Group Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
HKEX:2186 · Home$1.475 HKD-0.065 (-4.2%)51,541,458$1.41$1.48$1.38$1.54Close on Nov 20, 2026
Frankfurt:LUP€0.162 EUR-0.004 (-2.4%)—€0.162€0.162€0.162€0.166Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2186 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.475-0.065-4.2%$1.41$1.48$1.3851,541,458
$1.54+0.005+0.3%$1.55$1.55$1.50521,007,500
$1.535-0.01-0.6%$1.54$1.555$1.5123,934,500
$1.545-0.025-1.6%$1.58$1.58$1.53523,747,542
$1.57-0.065-4.0%$1.615$1.635$1.56523,052,000
$1.635-0.05-3.0%$1.685$1.685$1.6233,356,500
$1.685+0.005+0.3%$1.655$1.685$1.65513,532,500
$1.68+0.01+0.6%$1.69$1.70$1.66513,744,000
$1.67-0.005-0.3%$1.685$1.725$1.6611,890,000
$1.675-0.015-0.9%$1.63$1.69$1.62516,528,500
$1.69+0.07+4.3%$1.62$1.695$1.6242,709,000
$1.62+0.015+0.9%$1.605$1.63$1.57528,410,500
$1.6050.000.0%$1.61$1.625$1.57519,672,500
$1.605+0.02+1.3%$1.59$1.625$1.56517,222,500
$1.585+0.015+1.0%$1.565$1.60$1.54519,156,000
$1.57-0.035-2.2%$1.605$1.615$1.56523,780,500
$1.605+0.01+0.6%$1.60$1.61$1.58515,199,500
$1.595-0.01-0.6%$1.605$1.615$1.5816,427,664
$1.605+0.015+0.9%$1.595$1.61$1.5716,548,000
$1.59+0.01+0.6%$1.585$1.60$1.5536,948,000
$1.58-0.115-6.8%$1.695$1.695$1.5838,823,500
$1.695+0.01+0.6%$1.70$1.715$1.6815,331,500
$1.685-0.02-1.2%$1.705$1.715$1.67519,741,500
$1.705-0.015-0.9%$1.72$1.755$1.68530,872,002
$1.72+0.02+1.2%$1.70$1.72$1.6720,816,000
$1.70-0.01-0.6%$1.72$1.72$1.6811,492,798
$1.71-0.01-0.6%$1.72$1.72$1.65525,305,500
$1.72-0.01-0.6%$1.745$1.755$1.70514,568,000
$1.73-0.035-2.0%$1.775$1.78$1.72529,590,500
$1.765-0.025-1.4%$1.835$1.855$1.76531,632,000
$1.79-0.05-2.7%$1.865$1.865$1.7853,510,000
$1.84+0.035+1.9%$1.815$1.845$1.8152,134,000
$1.805-0.025-1.4%$1.72$1.82$1.722,481,000
$1.83-0.065-3.4%$1.89$1.89$1.788,243,000
$1.895+0.07+3.8%$1.815$1.895$1.81523,191,000
$1.825+0.04+2.2%$1.795$1.835$1.78516,376,000
$1.785-0.05-2.7%$1.86$1.905$1.7735,568,000
$1.835-0.05-2.7%$1.89$1.90$1.822,611,500
$1.885-0.025-1.3%$1.91$1.945$1.86524,507,500
$1.91+0.07+3.8%$1.845$1.92$1.82532,407,500
$1.84-0.035-1.9%$1.88$1.88$1.81527,272,000
$1.875+0.125+7.1%$1.775$1.925$1.75581,285,922
$1.75+0.05+2.9%$1.72$1.77$1.70546,735,855
$1.70-0.065-3.7%$1.76$1.76$1.6952,330,473
$1.765-0.03-1.7%$1.795$1.795$1.74534,259,500
$1.795+0.005+0.3%$1.79$1.81$1.7711,242,000
$1.79-0.01-0.6%$1.79$1.83$1.7720,816,000
$1.80-0.03-1.6%$1.82$1.82$1.7916,109,500
$1.83-0.035-1.9%$1.86$1.86$1.8029,025,500
$1.865-0.055-2.9%$1.915$1.915$1.8523,020,000
$1.92+0.035+1.9%$1.89$1.925$1.86514,177,500
$1.885-0.01-0.5%$1.89$1.905$1.85524,612,000
$1.895+0.02+1.1%$1.895$1.91$1.86518,418,500
$1.875+0.03+1.6%$1.845$1.90$1.84526,557,500
$1.845-0.055-2.9%$1.90$1.91$1.83529,449,500
$1.90-0.04-2.1%$1.94$1.95$1.8842,259,500
$1.94-0.19-8.9%$2.125$2.125$1.875104,662,000
$2.13-0.015-0.7%$2.145$2.195$2.09534,007,500
$2.145-0.025-1.2%$2.17$2.22$2.08564,106,000
$2.17+0.02+0.9%$2.17$2.23$2.15530,129,639
$2.15+0.045+2.1%$2.105$2.185$2.09518,779,500
$2.105-0.055-2.5%$2.17$2.17$2.0928,617,500
$2.16+0.015+0.7%$2.21$2.315$2.1588,265,508
$2.145+0.155+7.8%$2.04$2.185$2.03100,124,031
Ticker
Dusseldorf:LUP
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

Interim Report 2026

Sep 29, 2026

Closed $1.90 (+3.8%) on Sep 30, 2026

All Luye Pharma Group Ltd. news

Luye Pharma Group Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
13 in the last 12 months · 35 in all · newest Nov 19, 2026 · oldest 2023

Where Luye Pharma Group Ltd. is listed

ListingExchangeCountryCurrency
HKEX:2186 綠葉製藥 · Home listingHKEXHong KongHKD
OTC:LYPHFOTCUnited StatesUSD
gettex:LUPgettexGermanyEUR
LS Exchange:A116Z9LS ExchangeGermanyEUR
Lang & Schwarz:A116Z9Lang & SchwarzGermanyEUR
Frankfurt:LUPFrankfurtGermanyEUR
Dusseldorf:LUP · This pageDusseldorfGermanyEUR
Munich:LUPMunichGermanyEUR
Stuttgart:LUPStuttgartGermanyEUR

Valuation

P/E 8.1× against a median of 22.2×: the lowest of 6 Pharmaceuticals companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$7.99B HKD
P/E
8.1×
EV/sales
1.1×
EV/EBITDA
3.3×
Price/book
0.3×
Gross margin
66.0%
Operating margin
19.7%
Net margin
9.8%
Debt to equity
0.8×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Luye Pharma Group Ltd. · HKEX:2186US$751.7MUS$1.02B8.1×1.1×3.3×0.3×9.8%0.8×n/a
Zhejiang Ausun Pharmaceutical Co., Ltd. Class A · SSE:603229US$780.2MUS$640.1Mn/a5.6×n/a2.3×−0.6%0.0×n/a
Jinghua Pharmaceutical Group Co., Ltd. Class A · SZSE:002349US$774.6MUS$606.2M22.2×2.7×n/a1.8×15.7%0.0×n/a
Dezhan Healthcare Co., Ltd. Class A · SZSE:000813US$768.0MUS$680.7Mn/a13.0×n/a1.1×−111.1%0.0×n/a
Knight Therapeutics, Inc. · TSX:GUDUS$763.1MUS$683.3M68.5×1.7×10.5×1.4×2.8%0.0×0.33
Guizhou Bailing Group Pharmaceutical Co., Ltd. Class A · SZSE:002424US$757.0MUS$728.7Mn/a2.1×n/a1.6×−5.5%0.0×n/a
Ardelyx, Inc. · NASDAQ:ARDXUS$751.6MUS$718.6Mn/a1.5×n/a4.6×−11.8%1.5×0.88
Genomma Lab Internacional SAB de CV Class B · BMV:LAB/BUS$740.5MUS$953.0M8.3×1.1×4.8×1.2×10.0%0.6×n/a
Bliss GVS Pharma Limited · NSE:BLISSGVSUS$735.1MUS$716.7M42.3×6.2×28.1×5.3×15.0%0.0×n/a
Hunan Fangsheng Pharmaceutical Co., Ltd. Class A · SSE:603998US$732.2MUS$694.9M14.9×2.5×n/a2.7×17.4%0.0×n/a
Wanbangde Pharmaceutical Holding Group Co., Ltd. Class A · SZSE:002082US$729.9MUS$658.8Mn/a5.0×n/a1.9×−20.2%0.1×n/a
Median of the othersUS$754.3MUS$689.1M22.2×2.6×10.5×1.9×1.1%0.0×0.61

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
2.83 HKD · Analysts' mean
EPS, year to Dec 2026
0.17 · 2 analysts
Revenue, year to Dec 2026
6.16B · 2 analysts

Events

QuarterResultsShare move
Q2 2025Aug 28, 2025+3.8%
Quarter to Mar 31, 2025Apr 29, 2025+1.0%
Q4 2024Mar 30, 2025−13.3%
Quarter to Sep 30, 2024Nov 18, 2024−1.9%
Q2 2024Aug 28, 2024+5.2%
Quarter to Mar 31, 2024May 29, 2024−2.2%
Q4 2023Mar 27, 2024 · Before open0.0%
Quarter to Sep 30, 2023Nov 8, 2023−1.3%
Q2 2023Aug 29, 2023 · Before open+0.3%
Q1 2023May 31, 2023−0.3%
All 19 quarters
QuarterResultsShare move
Q4 2022Mar 29, 2023 · Before open+2.9%
Q3 2022Nov 9, 2022−0.9%
Q2 2022Aug 29, 2022 · Before open0.0%
Q1 2022Jun 1, 2022−4.9%
Q4 2021Mar 29, 2022 · After close−4.4%
Q3 2021Nov 10, 2021+3.0%
Q2 2021Aug 29, 2021 · Before open+4.3%
Q1 2021Jun 2, 2021−2.8%
Q4 2020Mar 31, 2021 · Before open−1.6%

Open Events

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue6.31B6.06B6.14B5.98B5.20B5.54B6.36B5.17B3.81B2.92B
Cost of revenue2.15B2.02B1.94B1.84B1.80B1.55B1.48B1.12B851.5M535.0M
Gross profit4.16B4.04B4.20B4.14B3.40B3.99B4.88B4.05B2.96B2.38B
Research and development413.9M498.6M586.2M857.3M683.2M789.9M579.5M491.2M288.7M193.7M
Selling, general and administrative679.6M582.0M644.0M582.9M570.8M521.5M525.9M441.4M431.6M267.0M
Operating income1.24B1.15B917.9M880.6M438.0M1.02B1.99B1.52B1.09B1.20B
Depreciation and amortization839.5M790.7M701.9M671.3M582.0M510.9M442.0M317.2M249.8M140.9M
EBITDA2.08B1.94B1.62B1.55B1.02B1.53B2.43B1.83B1.34B1.34B
Interest expense686.6M561.8M675.5M471.8M399.5M424.0M274.6M170.6M50.4M30.4M
Income before tax944.6M839.2M700.1M669.8M-74.6M942.2M1.77B1.47B1.12B974.7M
Income tax239.0M194.2M161.0M86.5M70.2M238.9M279.8M167.5M135.8M80.7M
Net income618.7M471.9M532.6M604.8M-134.4M706.6M1.47B1.30B981.4M891.5M
Earnings per share, basic0.160.130.140.17-0.040.230.470.400.300.27

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents4.50B4.94B3.24B2.32B2.44B3.87B2.33B1.67B1.27B397.8M
Short-term investments4.38B62.0M1.27B3.22B3.07B1.54B2.86B3.19B2.58B2.35B
Receivables3.26B4.30B2.35B1.78B1.77B1.81B1.83B1.63B1.41B1.55B
Inventory956.9M911.9M827.9M772.9M746.3M612.3M614.6M585.6M420.4M452.7M
Current assets15.2B13.3B10.7B10.8B10.4B9.97B9.36B8.68B6.30B5.28B
Property, plant and equipment6.06B6.05B5.15B4.59B4.20B4.02B3.42B2.84B2.01B1.70B
Goodwill1.08B1.01B1.04B1.00B985.4M1.06B1.04B1.04B1.04B995.9M
Total assets32.8B29.6B25.5B24.2B22.6B20.6B19.3B17.5B10.8B9.21B
Accounts payable1.15B689.3M767.2M559.9M570.9M485.3M298.5M279.8M104.6M116.1M
Current liabilities9.94B10.8B8.14B9.49B7.33B7.23B5.55B8.20B3.65B2.37B
Long-term debt3.59B2.69B3.18B2.24B4.21B4.33B4.50B847.5M232.0K0
Total debt9.42B10.3B8.42B9.10B9.49B9.97B7.37B4.04B2.86B2.35B
Total liabilities14.2B13.9B12.0B13.2B13.5B12.5B9.94B9.60B3.86B2.64B
Shareholders' equity16.1B14.2B12.5B10.2B8.49B7.89B8.83B7.81B6.77B6.43B
Shares outstanding3.90B3.76B3.73B3.48B3.45B3.14B3.16B3.27B3.26B3.32B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.78B167.8M1.60B1.65B182.4M1.03B1.74B1.05B964.1M592.0M
Capital spending-1.00B-1.71B-1.17B-1.16B-1.54B-1.52B-3.22B-2.48B-625.2M-319.1M
Free cash flow780.4M-1.54B430.2M490.1M-1.36B-486.4M-1.48B-1.44B338.9M272.9M
Cash from investing-3.99B-1.47B-1.42B-1.66B-3.44B138.2M-2.69B-3.00B-743.7M-1.83B
Cash from financing1.79B2.96B841.6M54.1M1.88B254.0M1.61B2.40B732.6M820.0M
Dividends paid0-175.5M-376.8M-289.7M-212.6M-107.0M
Share buybacks229.5M923.0M01.04B-78.0M-8.78M-21.6M-178.1M2.71M
Change in cash-445.6M1.70B915.2M-114.5M-1.43B1.54B652.6M407.0M868.1M-445.9M

Open Financials

Filings

Open Filings

Cap table

Built by 6ix from Luye Pharma Group Ltd.’s releases

Common shares
3,994,515,953
Fully diluted
3,994,515,953

Fully diluted

LineShares
Common shares3,994,515,953

Share count over time

CountShares
Nov 22, 20263,994,515,953

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
Luye Pharma Holdings Ltd.1.25B31.2%Sep 29, 2026
LuYe Pharmaceutical Investment Co., Ltd.1.25B31.2%Sep 29, 2026
Shorea LBG1.25B31.2%Sep 29, 2026
Ginkgo (PTC) Limited1.25B31.2%Sep 29, 2026
Luye Life Sciences Group Ltd1.25B31.2%Sep 29, 2026
Liu Dianbo1.25B31.2%Sep 29, 2026
LuYe Pharmaceutical International Co., Ltd.1.25B31.2%Sep 29, 2026
Nelumbo Investments Limited1.25B31.2%Sep 29, 2026
UBS Group AG561M14.0%Oct 13, 2026
Hillhouse Investment Management, Ltd.552M13.8%Sep 10, 2025
All 12 holders
HolderSharesOf the companyAs of
NEV Holdings Limited552M13.8%Sep 10, 2025
Hillhouse Fund V, L.P.552M13.8%Sep 10, 2025

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund31MUS$8.03MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund29.6MUS$7.68MJul 31, 2026
iShares Core MSCI Emerging Markets ETF24.9MUS$6.9MMay 31, 2026
Avantis Emerging Markets Equity ETF15.7MUS$4.36MMay 31, 2026
Emerging Markets Core Equity 2 Portfolio13.1MUS$3.39MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund5.17MUS$1.34MJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF3.61MUS$936KJul 31, 2026
iShares Core MSCI Total International Stock ETF3.04MUS$789KJul 31, 2026
The Emerging Markets Small Cap Series2.98MUS$773KJul 31, 2026
Schwab Emerging Markets Equity ETF2.32MUS$641KMay 31, 2026
All 41 holders
HolderSharesValueAs of
Dimensional Emerging Core Equity Market ETF2.15MUS$557KJul 31, 2026
Dimensional Emerging Markets Value Fund2.01MUS$521KJul 31, 2026
Vanguard Total World Stock Index Fund1.89MUS$491KJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account1.61MUS$372KJun 30, 2026
Fidelity Total International Index Fund1.6MUS$413KJul 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF1.57MUS$361KJun 30, 2026
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF1.41MUS$324KJun 30, 2026
iShares MSCI China Small-Cap ETF923KUS$256KMay 31, 2026
Dimensional Emerging Markets Value ETF732KUS$189KJul 31, 2026
Global X Aging Population ETF696KUS$193KMay 31, 2026
Avantis Emerging Markets Equity Fund596KUS$165KMay 31, 2026
World ex U.S. Core Equity Portfolio594KUS$154KJul 31, 2026
iShares MSCI Emerging Markets Small-Cap ETF476KUS$132KMay 31, 2026
Emerging Markets Sustainability Core 1 Portfolio465KUS$121KJul 31, 2026
Harbor International Core Fund441KUS$114KJul 31, 2026
Vanguard ESG International Stock ETF417KUS$116KMay 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio416KUS$95,485Jun 30, 2026
State Street(R) SPDR(R) S&P(R) China ETF369KUS$84,582Jun 30, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF292KUS$75,592Jul 31, 2026
Emerging Markets Targeted Value Portfolio283KUS$73,417Jul 31, 2026
Parametric Emerging Markets Fund250KUS$64,726Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF248KUS$64,201Jul 31, 2026
Avantis Emerging Markets Small Cap Equity ETF235KUS$65,032May 31, 2026
Franklin FTSE China ETF183KUS$42,004Jun 30, 2026
World ex U.S. Targeted Value Portfolio171KUS$44,362Jul 31, 2026
SA Emerging Markets Value Fund162KUS$37,066Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF117KUS$26,855Jun 30, 2026
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund90,000US$23,299Jul 31, 2026
Dimensional World ex U.S. Sustainability Targeted Value Portfolio63,000US$16,344Jul 31, 2026
Avantis Responsible Emerging Markets Equity ETF24,000US$6,656May 31, 2026
Franklin FTSE Asia ex Japan ETF10,500US$2,410Jun 30, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Luye Pharma Group Ltd.